Lineage Cell Therapeutics Inc (AMEX:LCTX)
$ 0.506 -0.014 (-2.69%) Market Cap: 114.62 Mil Enterprise Value: 84.66 Mil PE Ratio: 0 PB Ratio: 1.49 GF Score: 63/100

Q2 2019 BioTime Inc Earnings Call Transcript

Aug 08, 2019 / 08:30PM GMT
Release Date Price: $0.99 (-1.98%)
Operator

Welcome to the BioTime Incorporated Second Quarter 2019 Conference Call. (Operator Instructions) An audio webcast of this call is available on the Investors section of BioTime's website at www.biotime.inc.com. This call is subject to copyright and is the property of BioTime. Any recordings, reproduction and transmission of this call without the expressed written consent of BioTime are strictly prohibited. As a reminder, today's call is being recorded. I would now like to introduce your host for today's conference.

Ioana Hone, Director of Investor Relations at BioTime. Ms. Hone, please go ahead.

Ioana C. Hone
Lineage Cell Therapeutics, Inc. - Director of IR

Thank you, Chris. Good afternoon, and thank you for joining us. A press release reporting our second quarter 2019 financial results was issued earlier today, August 8, 2019, and can be found on the Investors section of our website.

Please note that today's conference call and webcast will contain forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot